JONG-MI LEE: Open Payments
NPI 1134356280 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,294 in 49 payments from 7 companies in 2025. Trend: 2023 $47,631 · 2024 $6,365 · 2025 $26,294
Consulting: $21,271Travel & lodging: $3,036Food & beverage: $1,927Education: $61
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $6,475 |
| Novartis Pharmaceuticals Corporation | 15 | $6,116 |
| Amgen Inc. | 13 | $6,040 |
| Biogen, Inc. | 11 | $5,468 |
| Alexion Pharmaceuticals, Inc. | 2 | $2,045 |
| TG Therapeutics, Inc. | 1 | $115 |
| EMD Serono, Inc. | 1 | $35 |
Products named: UPLIZNA, KESIMPTA, TYSABRI, BRIUMVI, ULTOMIRIS.
Industry payments across CA — which companies pay providers there.
